Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Inventory Average (2021 - 2025)

Historic Inventory Average for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to $67.4 million.

  • Xeris Biopharma Holdings' Inventory Average rose 5295.13% to $67.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.4 million, marking a year-over-year increase of 5295.13%. This contributed to the annual value of $43.5 million for FY2024, which is 3687.1% up from last year.
  • According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Inventory Average is $67.4 million, which was up 5295.13% from $60.0 million recorded in Q2 2025.
  • Xeris Biopharma Holdings' Inventory Average's 5-year high stood at $67.4 million during Q3 2025, with a 5-year trough of $16.2 million in Q4 2021.
  • In the last 5 years, Xeris Biopharma Holdings' Inventory Average had a median value of $37.9 million in 2023 and averaged $36.1 million.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 9648.76% in 2023, then surged by 1796.31% in 2024.
  • Over the past 5 years, Xeris Biopharma Holdings' Inventory Average (Quarter) stood at $16.2 million in 2021, then soared by 38.62% to $22.4 million in 2022, then surged by 71.62% to $38.5 million in 2023, then grew by 21.19% to $46.6 million in 2024, then surged by 44.43% to $67.4 million in 2025.
  • Its Inventory Average stands at $67.4 million for Q3 2025, versus $60.0 million for Q2 2025 and $50.4 million for Q1 2025.